Accretive Health Names David Mason as Chief Strategy Officer
November 11 2014 - 8:00AM
Business Wire
Accretive Health, Inc. (OTC Pink: ACHI) today announced that it
has appointed David Mason as chief strategy officer, effective
today.
“Dave brings both significant strategic and operational
expertise in the healthcare industry to this position, as well as a
proven track record of innovation,” said Emad Rizk, M.D., president
and CEO, Accretive Health. “I know of no one better qualified than
Dave to help Accretive Health successfully leverage our expertise,
expand our capabilities and solidify our position as a proven
industry leader.”
Mason brings more than 30 years of healthcare management and
hospital revenue cycle experience to Accretive Health, most
recently as senior vice president and general manager at
RelayHealth, which he joined in 2007. While there, Mason led the
company’s Financial Solutions division, where he was responsible
for all business operations, business development, strategic
planning, product management, client relationships and payer
services.
Prior to that, Mason was president of Per-Se Technologies’
Hospital Solutions division, and CEO and executive director of
Quantum Radiology. He also held practice management and
administration positions at Georgetown University Hospital in
Washington, D.C., and Northside Hospital in Atlanta, Ga. He holds a
Bachelor of Science degree in Healthcare Administration from
Southern Illinois University.
“As Accretive Health’s chief strategy officer, I look forward to
working with the leadership team and our talented sales and
operations organizations to enhance our comprehensive suite of
products and services to help our customers more effectively manage
their financial performance,” Mason said. “At the same time, we
will have to provide them with the platform and support they need
to develop the capabilities required to successfully navigate
complex changes occurring in the healthcare industry today and in
the future.”
About Accretive Health
At Accretive Health, our mission is to partner with healthcare
communities to serve as a catalyst for a healthier future for all.
For more information, visit www.accretivehealth.com.
Safe Harbor
This press release contains forward-looking statements,
including statements regarding Accretive Health’s future business
and growth prospects, and its ability to enhance its product and
service offerings. All forward-looking statements contained in this
press release involve risks and uncertainties. The company’s actual
results and outcomes could differ materially from those anticipated
in these forward-looking statements as a result of various factors,
including the possibility that the ongoing restatement could have
unanticipated consequences and the factors set forth in the
company’s quarterly report on Form 10-Q for the quarter ended
September 30, 2012, filed with the SEC on November 8, 2012, under
the heading “Risk Factors.” The words “strive,” “objective,”
“anticipates,” “believes,” “estimates,” “expects,” “intends,”
“may,” “plans,” “projects,” “vision,” “would,” and similar
expressions are intended to identify forward-looking statements,
although not all forward-looking statements contain these
identifying words. The company has based these forward-looking
statements on its current expectations and projections about future
events. Although the company believes that the expectations
underlying any of its forward-looking statements are reasonable,
these expectations may prove to be incorrect and all of these
statements are subject to risks and uncertainties. Should one or
more of these risks and uncertainties materialize, or should
underlying assumptions, projections, or expectations prove
incorrect, actual results, performance, financial condition, or
events may vary materially and adversely from those anticipated,
estimated, or expected.
All forward-looking statements included in this press release
are expressly qualified in their entirety by these cautionary
statements. The company cautions readers not to place undue
reliance on any forward-looking statement that speaks only as of
the date made and to recognize that forward-looking statements are
predictions of future results, which may not occur as anticipated.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the uncertainties and factors described above, as well as others
that the company may consider immaterial or does not anticipate at
this time. Although the company believes that the expectations
reflected in its forward-looking statements are reasonable, the
company does not know whether its expectations may prove correct.
The company’s expectations reflected in its forward-looking
statements can be affected by inaccurate assumptions it might make
or by known or unknown uncertainties and factors, including those
described above. The risks and uncertainties described above are
not exclusive, and further information concerning the company and
its business, including factors that potentially could materially
affect its financial results or condition or relationships with
customers and potential customers, may emerge from time to time.
The company assumes no, and it specifically disclaims any,
obligation to update, amend, or clarify forward-looking statements
to reflect actual results or changes in factors or assumptions
affecting such forward-looking statements. The company advises
investors, however, to consult any further disclosures it makes on
related subjects in our periodic reports that it files with or
furnishes to the SEC.
Accretive Health, Inc.Investor Relations:Atif
Rahim312-324-5476investorrelations@accretivehealth.comorMedia
Relations:Brian Pitts312-475-5921brian.pitts@hkstrategies.com
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Aug 2024 to Sep 2024
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Sep 2023 to Sep 2024